Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial

ABSTRACT Background Low energy diets (LEDs) are effective for body weight (BW) loss and improvement of type 2 diabetes (T2D) risk biomarkers. Emerging evidence suggests that whole fruit feijoa powder, rich in polyphenols and abscisic acid, may further support T2D prevention. The FERDINAND study investigated whether daily consumption of a whole fruit feijoa powder enhanced LED‐driven improvements in fasting plasma glucose (FPG), BW, and other metabolic markers. Methods At in‐clinic screening, 97 participants were enrolled into the trial and randomised to receive 1150 mg/day of whole fruit feijoa powder (Fx, n = 48) or Placebo treatment ( n = 49) for 6 months. All participants underwent 2 months of LED‐induced weight loss, followed by 4 months of dietary advice for weight loss maintenance. BW, FPG, and secondary outcomes including blood pressure (BP) were assessed at baseline (M0) and the end of months 2 (M2), 4 (M4), and 6 (M6). Data were analysed using linear mixed‐effects models as intention‐to‐treat (ITT) with imputation for missing not‐at‐random data points. Results BW decreased in both treatment groups during the 2‐month LED, with a gradual upward trajectory over the subsequent 4 months (time 0‐6m : p < 0.001). There was no difference in BW between Fx and Placebo over the 6‐month intervention (treatment×time 0‐6m : p = 0.74). FPG followed the weight loss trajectory in both treatment groups (time 0‐6m : p < 0.001), but with no between‐group interaction over 6 months (treatment×time 0‐6m : p = 0.09, n = 97). Systolic BP (SBP), but not diastolic BP, declined over the 6 months between treatments (treatment×time 0‐6m : p = 0.01) in all participants, with SBP in Fx lower than Placebo at M4 and M6 ( p < 0.05, both). Conclusions In adults with overweight (predominantly obesity) and prediabetes, Fx supplementation may enhance blood pressure improvement achieved through BW loss. The polyphenolic matrix of whole fruit feijoa, which contains a high proportion of catechins, may have contributed to vascular benefits.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-09-01
DOI
https://doi.org/10.1111/dom.71270
Primary Topic
Psidium guajava Extracts and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial

Ivana R. Sequeira, Rinki Murphy, Jennifer L. Miles‐Chan, Sally D. Poppitt et al.
Diabetes Obesity and Metabolism
Psidium guajava Extracts and Applications
article

Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial

Ivana R. Sequeira, Rinki Murphy, Jennifer L. Miles‐Chan, Sally D. Poppitt, Jia Jiet Lim, Lindsay D. Plank, I. A. Mohamed
article en

Abstract

ABSTRACT Background Low energy diets (LEDs) are effective for body weight (BW) loss and improvement of type 2 diabetes (T2D) risk biomarkers. Emerging evidence suggests that whole fruit feijoa powder, rich in polyphenols and abscisic acid, may further support T2D prevention. The FERDINAND study investigated whether daily consumption of a whole fruit feijoa powder enhanced LED‐driven improvements in fasting plasma glucose (FPG), BW, and other metabolic markers. Methods At in‐clinic screening, 97 participants were enrolled into the trial and randomised to receive 1150 mg/day of whole fruit feijoa powder (Fx, n = 48) or Placebo treatment ( n = 49) for 6 months. All participants underwent 2 months of LED‐induced weight loss, followed by 4 months of dietary advice for weight loss maintenance. BW, FPG, and secondary outcomes including blood pressure (BP) were assessed at baseline (M0) and the end of months 2 (M2), 4 (M4), and 6 (M6). Data were analysed using linear mixed‐effects models as intention‐to‐treat (ITT) with imputation for missing not‐at‐random data points. Results BW decreased in both treatment groups during the 2‐month LED, with a gradual upward trajectory over the subsequent 4 months (time 0‐6m : p < 0.001). There was no difference in BW between Fx and Placebo over the 6‐month intervention (treatment×time 0‐6m : p = 0.74). FPG followed the weight loss trajectory in both treatment groups (time 0‐6m : p < 0.001), but with no between‐group interaction over 6 months (treatment×time 0‐6m : p = 0.09, n = 97). Systolic BP (SBP), but not diastolic BP, declined over the 6 months between treatments (treatment×time 0‐6m : p = 0.01) in all participants, with SBP in Fx lower than Placebo at M4 and M6 ( p < 0.05, both). Conclusions In adults with overweight (predominantly obesity) and prediabetes, Fx supplementation may enhance blood pressure improvement achieved through BW loss. The polyphenolic matrix of whole fruit feijoa, which contains a high proportion of catechins, may have contributed to vascular benefits.

Diabetes Obesity and Metabolism
Statistics New Zealand (NZ), University of Auckland (NZ), Auckland University of Technology (NZ), Auckland District Health Board (NZ), Maurice Wilkins Centre (NZ), Riddet Institute (NZ), Massey University (NZ)
University of Auckland, National Science Council, Ministry of Business, Innovation and Employment
Good health and well-being
Openalex Percentile: Top 10%
Psidium guajava Extracts and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.